Guoxin Diagnostic Biotechnology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Guoxin Diagnostic Biotechnology - overview
Established
2025
Location
Hefei, Anhui, China
Primary Industry
Medical Devices & Equipment
About
Based in Hefei, China, and founded in 2025, Anhui Guoxin Diagnostic Biotechnology Co. , Ltd. , trading as Guoxin Diagnostic Biotechnology, is a developer of electrochemical intelligent biosensor technology, primarily engaged in the research and development of portable multi-parameter electrochemical immunoassay platforms to meet medical diagnostic needs. In January 2026, Guoxin Diagnostic Biotechnology raised a venture funding from PKU Collaborative Venture.
The company focuses on the research and application of POCT technology, dedicated to developing portable, rapid-result diagnostic devices to meet the needs of home self-testing, primary healthcare, and other scenarios. The company’s revenue is generated by providing electrochemical intelligent biosensor technology.
Current Investors
PKU Collaborative Venture
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment, Software
Verticals
HealthTech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.